Bulk deals: Quant MF buys 1.1% stake in Aarti Pharmalabs

representative image

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Quant Mutual Fund bought a 1.1 percent stake in Aarti Pharmalabs Limited via a bulk deal on May 22. Quant Mutual Fund bought around 10 lakh shares at an average price of Rs 575.83 per share.

Baron Emerging Markets Fund sold a 0.95 percent stake in Aarti Pharmalabs Limited. It sold around 8.6 lakh shares at an average price of Rs 573 per share. Baron Emerging Fund held a 1.01 percent stake in Aarti Pharmalabs as of April 30.

Aarti Pharmalabs' shares closed 6.14 percent up at Rs 615 on the National Stock Exchange.

Axis Mutual Fund bought a 1.04 percent stake or around 25 lakh shares in Granules India. It bought them at an average price of Rs 405.1 per share. The Massachusetts Institute of Technology also bought a 1.07 percent stake in Granules India. It bought around 25 lakh share at an average price of Rs 405.1 per share.

On the sellers side, promoter Krishna Prassad Chigurupati sold a 3.09 percent stake in Granules India or 75 lakh shares for an average price of Rs 405.08 per share. Krishna Prassad Chigurupati had a 34.78 percent stake in Granules India as of March 34.

Granules India shares closed 4.61 percent up, at Rs 427.95 on the National Stock Exchange.

Morgan Stanley Asia Singapore PTE bought a 0.63 percent stake in Apollo Tyres. It bought 40 lakh shares for an average price of Rs 477.35 per share.  While ICICI Prudential Mutual Fund bought a 0.66 percent stake in Apollo Tyres or 41 lakh shares for an average price of Rs 477.35 per share.

White Iris Investment Limited sold 2.2 crore shares of Apollo Tyres or a 3.54 percent stake in the company for an average price of Rs 477.35 per share. As of March 30, White Iris Investment Limited held a 3.54 percent stake in Apollo Tyres.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​​​